Urinary proteomics revealed prostaglandin H 2D-isomerase, not Zn-α2-glycoprotein, as a biomarker for active lupus nephritis

Journal of Proteomics

Volumn 75, Issue 11, 2012, Pages 3240-3247

  Somparn, Poorichaya ^a   Hirankarn, Nattiya ^a   Leelahavanichkul, Asada ^a   Khovidhunkit, Weerapan ^b   Thongboonkerd, Visith ^c,d   Avihingsanon, Yingyos ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Biomarker; Lupus nephritis; Prostaglandin H 2D isomerase; Proteomics; Urine; Zn 2 glycoprotein

Indexed keywords

ALPHA2 GLYCOPROTEIN; PROSTAGLANDIN D SYNTHASE; ZINC;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; ELECTROSPRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN URINE LEVEL; PROTEOMICS; TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; URINALYSIS; URINE;

BIOLOGICAL MARKERS; CARRIER PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; LIPOCALINS; LUPUS NEPHRITIS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84861717304     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.03.034     Document Type: Article

References (30)

1. Avihingsanon Y., Hirankarn N. Major lupus organ involvement: severe lupus nephritis. Lupus 2010, 19:1391-1398.
2. Balow J.E. Clinical presentation and monitoring of lupus nephritis. Lupus 2005, 14:25-30.
3. Whittier W.L., Korbet S.M. UpToDate: indications for and complications of renal biopsy (accessed Jan 4, 2012). http://www.uptodate.com/contents/indications-for-and-complications-of-renal-biopsy/.
4. Mosley K., Tam F.W., Edwards R.J., Crozier J., Pusey C.D., Lightstone L. Urinary proteomic profiles distinguish between active and inactive lupus nephritis. Rheumatology (Oxford) 2006, 45:1497-1504.
5. Thongboonkerd V. Urinary proteomics: towards biomarker discovery, diagnostics and prognostics. Mol Biosyst 2008, 4:810-815.
6. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
7. Weening J.J., D'Agati V.D., Schwartz M.M., Seshan S.V., Alpers C.E., Appel G.B., et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004, 65:521-530.
8. Gladman D.D., Ibanez D., Urowitz M.B. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002, 29:288-291.
9. Thongboonkerd V., Chutipongtanate S., Kanlaya R. Systematic evaluation of sample preparation methods for gel-based human urinary proteomics: quantity, quality, and variability. J Proteome Res 2006, 5:183-191.
10. Li G., Waltham M., Anderson N.L., Unsworth E., Treston A., Weinstein J.N. Rapid mass spectrometric identification of proteins from two-dimensional polyacrylamide gels after in gel proteolytic digestion. Electrophoresis 1997, 18:391-402.
11. Praditpornsilpa K., Townamchai N., Chaiwatanarat T., Tiranathanagul K., Katawatin P., Susantitaphong P., et al. The need for robust validation for MDRD-based glomerular filtration rate estimation in various CKD populations. Nephrol Dial Transplant 2011, 26:2780-2785.
12. Thongboonkerd V. Current status of renal and urinary proteomics: ready for routine clinical application?. Nephrol Dial Transplant 2010, 25:11-16.
13. Suzuki M., Wiers K., Brooks E.B., Greis K.D., Haines K., Klein-Gitelman M.S., et al. Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis. Pediatr Res 2009, 65:530-536.
14. Zhang X., Jin M., Wu H., Nadasdy T., Nadasdy G., Harris N., et al. Biomarkers of lupus nephritis determined by serial urine proteomics. Kidney Int 2008, 74:799-807.
15. Thongboonkerd V. Practical points in urinary proteomics. J Proteome Res 2007, 6:3881-3890.
16. Irmak S., Tilki D., Heukeshoven J., Oliveira-Ferrer L., Friedrich M., Huland H., et al. Stage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancer. Proteomics 2005, 5:4296-4304.
17. Yeung D.C., Lam K.S., Wang Y., Tso A.W., Xu A. Serum zinc-alpha2-glycoprotein correlates with adiposity, triglycerides, and the key components of the metabolic syndrome in Chinese subjects. J Clin Endocrinol Metab 2009, 94:2531-2536.
18. Roher A.E., Maarouf C.L., Sue L.I., Hu Y., Wilson J., Beach T.G. Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease. Biomarkers 2009, 14:493-501.
19. Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong D.T., Loo J.A. Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry. J Proteome Res 2006, 5:1493-1503.
20. Schmitt R., Marlier A., Cantley L.G. Zag expression during aging suppresses proliferation after kidney injury. J Am Soc Nephrol 2008, 19:2375-2383.
21. Sanchez L.M., Chirino A.J., Bjorkman P. Crystal structure of human ZAG, a fat-depleting factor related to MHC molecules. Science 1999, 283:1914-1919.
22. Oates J.C., Varghese S., Bland A.M., Taylor T.P., Self S.E., Stanislaus R., et al. Prediction of urinary protein markers in lupus nephritis. Kidney Int 2005, 68:2588-2592.
23. Urade Y., Hayaishi O. Prostaglandin D synthase: structure and function. Vitam Horm 2000, 58:89-120.
24. Grill M., Peskar B.A., Schuligoi R., Amann R. Systemic inflammation induces COX-2 mediated prostaglandin D2 biosynthesis in mice spinal cord. Neuropharmacology 2006, 50:165-173.
25. Smith J.B. Prostaglandins and platelet aggregation. Acta Med Scand Suppl 1981, 651:91-99.
26. Satoh T., Moroi R., Aritake K., Urade Y., Kanai Y., Sumi K., et al. Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. J Immunol 2006, 177:2621-2629.
27. Monneret G., Gravel S., Diamond M., Rokach J., Powell W.S. Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 2001, 98:1942-1948.
28. Nagata N., Fujimori K., Okazaki I., Oda H., Eguchi N., Uehara Y., et al. De novo synthesis, uptake and proteolytic processing of lipocalin-type prostaglandin D synthase, beta-trace, in the kidneys. FEBS J 2009, 276:7146-7158.
29. Wu T., Fu Y., Brekken D., Yan M., Zhou X.J., Vanarsa K., et al. Urine proteome scans uncover total urinary protease, prostaglandin D synthase, serum amyloid P, and superoxide dismutase as potential markers of lupus nephritis. J Immunol 2010, 184:2183-2193.
30. Ogawa M., Hirawa N., Tsuchida T., Eguchi N., Kawabata Y., Numabe A., et al. Urinary excretions of lipocalin-type prostaglandin D2 synthase predict the development of proteinuria and renal injury in OLETF rats. Nephrol Dial Transplant 2006, 21:924-934.